Chemclin Diagnostics Co., Ltd. (SHA:688468)
6.19
-0.12 (-1.90%)
Jun 4, 2026, 3:00 PM CST
-15.09% (1Y)
| Market Cap | 2.44B -14.1% |
| Revenue (ttm) | 324.73M -23.7% |
| Net Income | 38.33M -65.4% |
| EPS | 0.09 -65.6% |
| Shares Out | 394.59M |
| PE Ratio | 67.88 |
| Forward PE | n/a |
| Dividend | 0.13 (1.85%) |
| Ex-Dividend Date | Jun 13, 2025 |
| Volume | 3,225,976 |
| Open | 6.30 |
| Previous Close | 6.31 |
| Day's Range | 6.13 - 6.35 |
| 52-Week Range | 6.15 - 9.12 |
| Beta | 0.07 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |